Greenleaf Health: Wilson Bryan, former FDA gene therapy leader, joins consulting firm
The agency veteran, who led the Office of Tissues and Advanced Therapies during a boom in gene and cell therapy research, retired in March.
Read full article »
Founder & CEO
Patrick Ronan
Greenleaf Health is a District of Columbia-based FDA regulatory consulting firm that provides compliance, advisory and related services for medical device companies.
Read more